GLP-1 Compounding Controversy: What Med Spa Owners Need to Know Key Takeaways The regulatory environment for compounded weight loss medications remains fluid, with FDA decisions creating uncertainty for med spa owners and their patients
The cytosolic GSTs are profusely present and have been divided into divergent classes based on their genesis, catalytic amino-acid residue, sequence similarity, and substrate specificity ( Figure 1 )
Erastin, the first ferroptosis inducer discovered, targets SLC7A11, leading to GSH depletion and subsequent GPX4 inactivation, leading to ferroptosis [8]
Imagine your stomach is holding onto food a little longer, like a dam holding back water
The higher 2.4 milligram dose, Wegovy, is approved and prescribed for long-term weight management